BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 20959456)

  • 1. Phosphorylated alpha-synuclein at Ser-129 is targeted to the proteasome pathway in a ubiquitin-independent manner.
    Machiya Y; Hara S; Arawaka S; Fukushima S; Sato H; Sakamoto M; Koyama S; Kato T
    J Biol Chem; 2010 Dec; 285(52):40732-44. PubMed ID: 20959456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assembly of lysine 63-linked ubiquitin conjugates by phosphorylated alpha-synuclein implies Lewy body biogenesis.
    Liu C; Fei E; Jia N; Wang H; Tao R; Iwata A; Nukina N; Zhou J; Wang G
    J Biol Chem; 2007 May; 282(19):14558-66. PubMed ID: 17360705
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates.
    Arawaka S; Sato H; Sasaki A; Koyama S; Kato T
    Acta Neuropathol Commun; 2017 Jun; 5(1):48. PubMed ID: 28619113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accumulation of phosphorylated tyrosine hydroxylase into insoluble protein aggregates by inhibition of an ubiquitin-proteasome system in PC12D cells.
    Kawahata I; Tokuoka H; Parvez H; Ichinose H
    J Neural Transm (Vienna); 2009 Dec; 116(12):1571-8. PubMed ID: 19756365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lewy body-like α-synuclein aggregates resist degradation and impair macroautophagy.
    Tanik SA; Schultheiss CE; Volpicelli-Daley LA; Brunden KR; Lee VM
    J Biol Chem; 2013 May; 288(21):15194-210. PubMed ID: 23532841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct alpha-Synuclein species induced by seeding are selectively cleared by the Lysosome or the Proteasome in neuronally differentiated SH-SY5Y cells.
    Pantazopoulou M; Brembati V; Kanellidi A; Bousset L; Melki R; Stefanis L
    J Neurochem; 2021 Mar; 156(6):880-896. PubMed ID: 32869336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accelerated formation of alpha-synuclein oligomers by concerted action of the 20S proteasome and familial Parkinson mutations.
    Lewis KA; Yaeger A; DeMartino GN; Thomas PJ
    J Bioenerg Biomembr; 2010 Feb; 42(1):85-95. PubMed ID: 20148295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural alkaloid harmine promotes degradation of alpha-synuclein via PKA-mediated ubiquitin-proteasome system activation.
    Cai CZ; Zhou HF; Yuan NN; Wu MY; Lee SM; Ren JY; Su HX; Lu JJ; Chen XP; Li M; Tan JQ; Lu JH
    Phytomedicine; 2019 Aug; 61():152842. PubMed ID: 31048127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Does proteasome [corrected] inhibition decrease or accelerate toxin-induced dopaminergic neurodegeneration?
    Setsuie R; Kabuta T; Wada K
    J Pharmacol Sci; 2005 Mar; 97(3):457-60. PubMed ID: 15764834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha-synuclein-enhanced green fluorescent protein fusion proteins form proteasome sensitive inclusions in primary neurons.
    McLean PJ; Kawamata H; Hyman BT
    Neuroscience; 2001; 104(3):901-12. PubMed ID: 11440819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
    Lee FK; Wong AK; Lee YW; Wan OW; Chan HY; Chung KK
    J Neurochem; 2009 Jul; 110(1):208-19. PubMed ID: 19457126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synphilin-1 degradation by the ubiquitin-proteasome pathway and effects on cell survival.
    Lee G; Junn E; Tanaka M; Kim YM; Mouradian MM
    J Neurochem; 2002 Oct; 83(2):346-52. PubMed ID: 12423244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha-synuclein is required for the fibrillar nature of ubiquitinated inclusions induced by proteasomal inhibition in primary neurons.
    Rideout HJ; Dietrich P; Wang Q; Dauer WT; Stefanis L
    J Biol Chem; 2004 Nov; 279(45):46915-20. PubMed ID: 15322100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 6-Hydroxydopamine increases ubiquitin-conjugates and protein degradation: implications for the pathogenesis of Parkinson's disease.
    Elkon H; Melamed E; Offen D
    Cell Mol Neurobiol; 2001 Dec; 21(6):771-81. PubMed ID: 12043847
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The novel mechanism of rotenone-induced α-synuclein phosphorylation via reduced protein phosphatase 2A activity.
    Wang Y; Liu J; Chen M; Du T; Duan C; Gao G; Yang H
    Int J Biochem Cell Biol; 2016 Jun; 75():34-44. PubMed ID: 27012437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine or biopterin deficiency potentiates phosphorylation at (40)Ser and ubiquitination of tyrosine hydroxylase to be degraded by the ubiquitin proteasome system.
    Kawahata I; Ohtaku S; Tomioka Y; Ichinose H; Yamakuni T
    Biochem Biophys Res Commun; 2015 Sep; 465(1):53-8. PubMed ID: 26225746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ubiquitination of alpha-synuclein in Lewy bodies is a pathological event not associated with impairment of proteasome function.
    Tofaris GK; Razzaq A; Ghetti B; Lilley KS; Spillantini MG
    J Biol Chem; 2003 Nov; 278(45):44405-11. PubMed ID: 12923179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Ser-129 phosphorylation on interaction of α-synuclein with synaptic and cellular membranes.
    Visanji NP; Wislet-Gendebien S; Oschipok LW; Zhang G; Aubert I; Fraser PE; Tandon A
    J Biol Chem; 2011 Oct; 286(41):35863-35873. PubMed ID: 21849493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lycorine, a natural alkaloid, promotes the degradation of alpha-synuclein via PKA-mediated UPS activation in transgenic Parkinson's disease models.
    Zhu Q; Zhuang XX; Chen JY; Yuan NN; Chen Y; Cai CZ; Tan JQ; Su HX; Lu JH
    Phytomedicine; 2021 Jul; 87():153578. PubMed ID: 34038839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specificity and regulation of casein kinase-mediated phosphorylation of alpha-synuclein.
    Waxman EA; Giasson BI
    J Neuropathol Exp Neurol; 2008 May; 67(5):402-16. PubMed ID: 18451726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.